166 results about "Rheumatic Heart Diseases" patented technology

The invention discloses a medical combination for treating pulmonary heart disease and rheumatic heart disease and the preparation method thereof; the invention is prepared by peach kernel, safflower, angelica, charles abraham, Szechwan Lovage Rhizome, red peony root, achyranthes root, balloonflower root, bupleurum, citrus aurantium, and licorice. The medical combination of the invention has the efficacy of activating blood, promoting qi and ending pains, mainly for the treatment of pulmonary heart disease, rheumatic heart disease, the chest pain and headache caused by the clotted blood and the unsmooth blood flow in the chest, and also for coronary angina pectoris, chest contusion, rib chondritis chest pain, neurosis, deprementia of the concussion of brain sequela, dizziness headache, and other diseases. The invention has the advantages of simple formula, easy production, convenient taking by the patients, obvious efficacy, and wide application value.

The invention discloses a formula of a rheumatism medicated wine for treating rheumatoid diseases; the main components of the formula comprises more than 20 Chinese medicinal herbs such as angelica polyclada, doubleteeth pubescent angelica root, radix sileris, radix astragali, salvia miltiorrhiza, panax ginseng, bee glue, nidus vespa, angelica, flowery knotweed root, Common Clubmoss Herb, Chinese clematis, Chinese quince and eucommia bark, and the like, the medicated wine can be drunk after 30 days of airtight soaking of the Chinese medicinal herbs with wine in a container, the best formula is obtained after over ten years of self experiences and clinical application and is characterized in that the formula treats a plurality of rheumatism and rheumatoid diseases during nourishment, the formula consists of the Chinese medicinal herbs aiming at treating and good Chinese medicinal herbs which tonify qi, adjust nutrition and nourish heart blood, activate blood circulation to dissipate blood stasis, produce blood and nourish yang, detoxify and relieve rheumatism, counteract a toxin, disperse cold, relax the tendons and activate collaterals, and the formula mainly treats the diseases such as lumbocrural spontaneous sweating and night sweating, myocardial blood deficient, rheumatism, rheumatoid bone diseases, hyperosteogeny, lumbar disc herniation and limb edema, etc. After long-term proper drinking, the blood pressure can be balanced, blood lipid can be reduced, and the outburst of rheumatic heart disease can be inhibited.

The invention discloses pills for treating a rheumatic heart disease and a preparation method thereof and belongs to the field of traditional Chinese medicines. Active ingredients of the pills comprise: by weight, 50 to 70 parts of cassia twig, 50 to 65 parts of mix-fried licorice root, 45 to 60 parts of dwarf lilyturf tuber, 45 to 60 parts of Chinese magnoliavine fruit, 40 to 55 parts of poria cocos, 40 to 50 parts of mix-fried milkvetch root, 40 to 50 parts of curcumae, 35 to 45 parts of pubescent holly root, 35 to 45 parts of red sage root, 30 to 40 parts of Chinese arborvitae kernel, 25 to 40 parts of snakegourd fruit, 20 to 30 parts of longan pulp, 20 to 30 parts of sichuan lovage rhizome, 15 to 30 parts of stir-fried milkwort root, 15 to 25 parts of grassleaf sweetflag rhizome and 10 to 25 parts of syzygium jambos seed. The pills utilizes the unique traditional Chinese medicines, has a good formula, has effects of tonifying qi, nourishing yin, dispelling wind, dissipating heat, relaxing muscles and tendons, invigorating the circulation of blood, strengthening vital qi and eliminating pathogens, and has good absorption effects, obvious curative effects, no toxic and side effect and no adverse clinical reactions. A clinical experiment proves that the pills have good effects of treatment on a rheumatic heart disease, and postoperative recovery.

The invention relates to a Chinese medicinal composition for treating a rheumatic heart disease. The composition is characterized by being prepared from the following raw materials in parts by weight: 12-18 parts of codonopsis pilosula, 12-18 parts of white poria, 12-18 parts of astragalus root, 12-18 parts of cortex acanthopanacis, 5-15 parts of dwarf lilyturf tuber, 5-15 parts of cassia twig, 5-15 parts of Chinese angelica, 5-15 parts of polygala root, 5-15 parts of white atractylodes rhizome, 5-10 parts of divaricate saposhnikovia root, 4-8 parts of root of red-rooted salvia, 4-8 parts of fructus schizandrae, 3-7 parts of honey-fried licorice root, and 3-7 parts of asarum. The composition has the advantages of treatment of both symptoms and root causes, remarkable curative effect, low cost, side effect prevention and capability of realizing thorough healing; and by clinical verification, the effective rate of the composition for treating the rheumatic heart disease is 99 percent.

The invention discloses Yang-freeing and Qi-boosting health-care tea, which is characterized in that the main ingredients comprise 15 to 30 grams of raw raidx astragali, 5 grams of liquoric root, 15 grams of codonopsis pilosula, 10 grams of cassia twig, 10 grams of ginseng and10 grams of mix-fried liquoric root; for treating the heart throb and knotted and intermittent pulse of patients with coronary heart disease, 10 grams of szechuan lovage rhizome, 20 grams of salvia miltiorrhiza bunge, 15 grams of raw keel, 15 grams of raw oyster, 15 grams of magnetitum, 40 grams of huai valleys grown wheat, 20 grams of pericarpium trichosanthis, 10 grams of turmeric root-tuber and 10 grams of orange fibers are added, or 10 grams of szechuan lovage rhizome, 20 grams of salvia miltiorrhiza bunge, 15 grams of raw keel, 15 grams of magnetitum and 40 grams of huai valleys grown wheat are added; for treating chest stuffiness and precardial pain, 20 grams of pericarpium trichosanthis, 10 grams of turmeric root-tuber, and 10 grams of orange fibers are added; for great pains, szechwan Chinaberry fruit which is raw medicament of Sichuan Chinaberry powder and corydalis yanhusuo W. T. Wang are semi-ground and taken with water for 2 to 3 times each day; for treating insomnia and dreaminess, spina date seed and platycladi seeds are added; for treating the heart throb of people with rheumatic heart disease, mulberry twig, gentiana macrophylla, turmeric and Chinese taxillus twig are added; and for treating the heart throb and chest stuffiness of people with myocarditis, lightyellow sophora root, salvia miltiorrhiza bunge, coastal glehnia root and the like are added. The preparation method comprises the following steps: mixing the medicaments; placing the mixture in a vessel and soaking the mixture in water for 25 minutes; decocting the mixture over a slow fire for 15 minutes; and obtaining about 200 milliliters of liquid to be taken in a day in two times.

The invention relates to a medicine for treating rheumatic heart disease, in particular to a traditional Chinese medicine composition for treating rheumatic heart disease which is made from plant Chinese herbal medicine. It is characterized in that, the raw material medicine that makes active ingredient is according to the following weight: Wujiapi 20-30 grams each, Radix Astragali 20-30 grams, Atractylodes macrocephala 20-30 grams, Poria cocos 15-25 grams, Radix Paeoniae Alba 15-25 grams , 5-15 grams of schisandra, 5-15 grams of licorice, 5-15 grams of salvia miltiorrhiza, 4-12 grams of cassia twig, 4-12 grams of sunburned aconite and 2-8 grams of asarum. All medicines of the present invention are compatible, complement each other, bring out the best in each other, have heat-clearing and toxic substances removing, expelling wind and relieving pain, regulating blood circulation and promoting blood circulation to remove blood stasis, eliminating stagnation and relieving pain etc., the synergistic action of drug effect can treat both symptoms and root causes, can reduce pathological integral, free radical, Reduce the autoimmune reaction of the heart, nourish the myocardium, improve blood supply and oxygen supply, and repair the lesion, thereby alleviating the pathological changes of the heart valve.

The invention discloses a medicine for treating cardiocerebrovascular diseases, which is mainly prepared by the following raw materials: coenzyme Q10 (CoQ10), Vitamin E (VE) and soybean lecithin (PC). The medicine is widely used for treating coronary heart disease, cardiac failure, arrhythmia, rheumatic heart disease, viral myocarditis, blood supply deficiency, high blood pressure, and other cardiocerebrovascular diseases and periodontitis resulted from gingival atrophy and also can be used as adjuvant therapy for acute and chronic viral hepatitis and cancer, which also has the efficacies of decreasing blood lipid, lowering cholesterol, regulating internal secretion, eliminating climacteric syndrome, resisting aging, preventing senile dementia, etc. In addition, the invention also discloses a production method for preparing the medicine for treating cardiocerebrovascular diseases with semisynthetic raw material.

The invention relates to a traditional Chinese medicine preparation for treating coronary heart diseases and angina pectoris, which is characterized by being prepared by grinding ginseng, radix salviae miltiorrhizae, rhizoma ligustici wallichii, astragalus root, Chinese eaglewood, leech, angelica, white atractylodes rhizome, safflower, sandalwood, dalbergia wood, clove, tall gastrodia tuber, mastic, rosa banksiae, cinnabar, white peony root, saltedaconiteroot and longstamen onion bulb after stir-frying into a dry state by using an iron pan, sieving by a sieve of 200 meshes to prepare medicinal powder and capsulating. The invention has better curative effect to the symptoms of cardiodynia, shortness of breath, insomnia, dreaminess, light headedness, body fatigue, impotence and the like caused by the diseases of coronary heart diseases, angina pectoris, rheumatic heart diseases, cerebral thrombus, vascular headache, lung primary heart diseases and the like, has short treating time, convenient application and quick actions of promoting blood circulation, relieving the stasis of blood and alleviating pain, can eliminate the common symptoms by one treatment course and eliminates the symptoms of a patient with serious state of an illness by three treatment courses. At present, the result of the clinical treatment of nearly thousands of various patients of different types with heart diseases shows that the total effective rate reaches more than 98%, and the rate of completely relieving the symptoms reaches more than 85%.

This invention is in the field of identifying patients having rheumatic heart disease (RHD) associated with Streptococcus pyogenes (Group A Streptococcus; GAS) infection and identifying patients at risk of developing RHD associated with GAS infection. The invention also provides methods and compositions for preventing and treating RHD associated with GAS infection.

The invention discloses a system for identifying and diagnosing rheumatic heart disease based on sound sensors. The system comprises the plurality of sound sensors placed on the surface of a thoracic cavity outside a heart, and the sound sensors are all connected with a signal processing system which is connected with monitor terminal equipment. A method for identifying and diagnosing the rheumatic heart disease based on the sound sensors comprises the steps: placing the sound sensors on the surface of the thoracic cavity outside the heart, transmitting heart sounds detected by the sound sensors to the signal processing system, performing three-dimensional sound source positioning signal processing, and finally obtaining a position where cardiac souffle is made, wherein the position is shown on the screen of the monitor terminal equipment in icon and three-dimensional coordinate forms. The system and the method have the advantages that a cardiac souffle situation can be accurately obtained by auscultation, and the position of a souffle sound source can be exactly positioned and be displayed on a displayer in real time. By adopting the method and the equipment of the system, the rheumatic heart disease can be well diagnosed according to the heart sounds.

The present invention provides an herbal pharmaceutical compositions comprising the root of scutellaria, the rhizome of coptis, the root and rhizome of rhubarb, and the dry powders of the root of ginseng (or American ginseng) or the rhizome of ginger. The herbal pharmaceutical compositions are effective in preventing patients from developing or treating patients with cardiovascular diseases, which include, but are not limited to, hypertension, coronary heart disease, cerebrovascular disease, peripheral vascular disease, heart failure, rheumatic heart disease, congenital heart disease, and cardiomyopathies. The present invention also provides methods for preparing and using the herbal pharmaceutical compositions.

The invention relates to a traditional Chinese medicine for treating childhood rheumatic heart disease. The medicine is composed of ingredients according to the parts by weight: 20-60 parts of radix astragali, 5-10 parts of ginseng, 3-15 parts of prepared common monkshood daughter root, 4-6 parts of baked ginger, 6-10 parts of cassia twig, 6-12 parts of rhizoma ligustici wallichii, 10-15 parts of Chinese taxillus twig, 10-20 parts of ophiopogon root, 9-15 parts of tuckahoe, 10-20 parts of atractylis ovata, 5-10 parts of pepperweed seed, 6-10 parts of roasted liquorice. In the medicine, the ginseng reinforces vital energy; the prepared common monkshood daughter root revives the yang for resuscitation; the radix astragali, the atractylis ovata and the tuckahoe have the same functions of invigorating qi, supporting the healthy energy, strengthening the spleen and excreting dampness; the rhizoma ligustici wallichii, the ginseng and the cassia twig have the same functions of activating blood and dissolving stasis, strengthening yang, transforming qi and activating collateral flow. The rest medicines have the functions of strengthening heart, increasing the coronary blood flow and improving the circulation, thereby having good effects on treating the childhood rheumatic heart disease.

The invention relates to a novel stable protein kinase activator adenosine cyclophosphate salt derivate, which has high storage stability and preparation performance and can be used in the preparation of medicaments for treating or preventing the following human and animal diseases such as stenocardia, cardiac failure, myocardial infarction, myocarditis, arrhythmia, cardiogenicshock, acute leukemia, nerve system diseases, respiratory system diseases, senile chronic bronchitis, hepatitis, psoriasis and the like and relieving the symptoms, such as cardiopalmus, shortness of breath, chest distress and the like of rheumatic heart disease.

An interior-applied Chinese medicine for treating rheumatic heart disease is prepared from 25 Chinese-medicinal materials including Chinese angelica root, coix seed, rehmannia rot, etc.

The invention particularly relates to a traditional Chinese medicine for treating rheumatic heart disease, belonging to the technical field of the Chinese medicine. The traditional Chinese medicine comprises the following raw material medicines in part by weight: 2-4 parts of folium mori, 2-4 parts of spanishneedles herb, 1-3 parts of dried orange peel, 4-6 parts of mourning of the chaste tree flower, and 0.5-2 parts of bletilla. The traditional Chinese medicine has good effect for treating the rheumatic heart disease.

The invention discloses an Rh blood type typing method and device based on multiplex PCR (Polymerase Chain Reaction) and second-generation sequencing. RHD (Rheumatic Heart Disease) and RHCE genes havevery high similarity; during the amplification comparison to the human genome reference sequence, the problem of wrong comparison easily occurs. A multiplex PCR primer sequence is cut and removed before the comparison; the matching precision of the sequence can be improved; the wrong judgment on the typing result caused by wrong comparison is avoided; the Rh blood type typing accuracy rate is greatly improved; the occurrence of false positive result can be avoided.

The invention relates to a health care food, and in particular relates to a fruit and vegetable heart nourishing tea and a preparation method of the tea. The fruit and vegetable heart nourishing tea comprises pueraria flavone, seabuckthorn flavone, ginkgo flavone, soy isoflavone, coenzyme Q10, red ginseng, salviae miltiorrhizae, rhizoma alismatis, radix astragali, malt, blueberries, barbary wolfberry fruit and the like, and is prepared by grinding the cytoplasm of the raw materials in an ultrasonic way to obtain irregular granules. The fruit and vegetable heart nourishing tea can be used for the adjuvant therapy of various heart diseases in a way of dietary therapy, aims at the people with coronary heart disease, pulmonary heart disease, rheumatic heart disease, myocarditis, hypertension, hyperglycemia, hyperlipidemia, diabetes mellitus and the like, is strong in activity and high in cure rate, and enables the diseases not to easily relapse after the diseases are cured.

The invention discloses a traditional Chinese medicine combination used for curing heart disease, which is characterized in that the invention is prepared by the following compositions in portions by weight: 60-100 portions of rehmanniae vaporata, 30-50 portions of Chinese yam rhizome, 30-50 portions of common macrocarpium, 13-18 portions of cortex moutan, 13-18 portions of China root green birer rhizome, 13-18 portions of alisma orientale, 8-12 portions of cassia bark, 2-5 portions of hairy antler, 2-5 portions of tortoise plastron, 1-3 portions of schisandra chinensis and 1 portion of amomum villosum powder. The invention essentially cures coronary heart disease, pulmonary heart disease, rheumatic heart disease as well as hypertensive heart disease and congenital heart disease; the invention reaches 100 percent efficiency and 95 percent cure rate within one year when the heart disease attacks; symptoms of 5 percent of aged patients and patients who have two long duration of disease and systemic failure can be promoted, thus prolonging life-span.

The invention discloses a traditional Chinese medicine composition for treating rheumatic heart disease. The traditional Chinese medicine composition is prepared from the following raw materials by weight: 3-8g of lotus seed, 3-8g of fructus gardenia, 5-15g of radix polygonati officinalis, 5-15g of schisandra chinensis, 5-15g of radix stephaniae tetrandrae, 5-15g of fructus aurantii immaturus, 5-15g of radix ophiopogonis, 5-15g of cassia twig, 5-15g of radix bupleuri, 5-15g of cortex acanthopanacis, 5-15g of radix paeoniae rubra, 5-15g of angelica sinensis, 10-20g of radix curcumae, 10-20g of semen plantaginis, 10-20g of codonopsis pilosula, 10-20g of radix salviae miltiorrhizae, 10-20g of radix rehmanniae, 10-20g of radix stephaniae tetrandrae, 10-20g of raw gypsum, 10-20g of radix gentianae macrophyllae, 15-25g of radix polygoni multiflori, 15-25g of loranthus parasiticus, 15-25g of radix astragali and 3-8g of liquorice. By combining the medicines, the composition has a synergistic effect; the traditional Chinese medicine composition for treating rheumatic heart disease has the functions of invigorating qi and enriching blood, warming yang and restoring pulse, promoting circulation and removing stasis and consolidating body resistance and nourishing vigour; moreover, the medicines have the advantages of no side effect to the body, no negative influence on the health of the patients and the like. By virtue of clinical experiment, a relatively high cure rate is achieved.

The invention discloses application of mesenchymal stem cells in preparation of products for treating rheumatoid arthritis. The invention provides application of the mesenchymal stem cells or cell preparations of the mesenchymal stem cells in preparation of drugs for treatment of rheumatoid arthritis. The preparation method of the cell preparations includes the following steps: adopting a tissue block in a Warton zone of the umbilical cord as a raw material, and preparing the umbilical cord mesenchymal stem cells so as to obtain the cell preparations, wherein a low-serum culture medium is adopted in the preparation process. The cell preparations are suitable for cell therapy of rheumatoid arthritis and other diseases related to rheumatoid arthritis, wherein complications and diseases withsimilar pathogenesis of the diseases related to rheumatoid arthritis include rheumatoid vasculitis, pneumonia, osteoarthritis, rheumatoid heart disease, ankylosing spondylitis, gout, eye diseases, kidney diseases, urinary system infection, Cushing's syndrome, oral ulcers and other diseases. A great application value is provided for treatment of rheumatoid arthritis and related diseases.

An interior-applied Chinese medicine for treating rheumatic heart disease is prepared from 9 Chinese-medicinal materials including Chinese angelica root, pilose asiabell root, astragalus root, cinnamon twig, etc.

The invention belongs to the field of traditional Chinese medicament, and in particular discloses a traditional Chinese medicament for treating rheumatic heart disease. The traditional Chinese medicament consists of radix polygonati officinalis, rohdea japonica, raw rehmanniae, motherwort, bamboo leaves, turpentine, coix seeds, eggplant root, safflower, peach kernels, Chinese date, weeping forsythiae capsule, Chinese magnoliavine fruit, mulberry twig, roasted liquorice, pear leaves and flower of silktree albizzia serving as active components in certain parts by weight. The traditional Chinese medicament has simplicity in preparation, good absorption effect, remarkable curative effect, no side effect and high safety, and is advantageous to lighten symptom of patients in time.

An interior-applied Chinese medicine for treating rheumatic heart-disease is prepared from 11 Chinese-medicinal materials including pilose asiabell root, astragalus root, Chinese angelica root, cinnamon twig, etc.

The invention discloses a deer heart blood soft capsule, which is characterized by consisting of the following bulk pharmaceuticals in parts by weight: 40g of deer heart blood, 30g of lucid ganoderma, 5g of rhodiola rosea, 3g of snow lotus, 10g of red ginseng, 5g of straight ladybell root, 10g of royal jelly, 10g of astragalus, 5g of American ginseng and 5g of blueberry. The deer heart blood of deer, and lucid ganoderma, rhodiola rosea and snow lotus which are extracted at a high concentration are prepared into a soft capsule, so that the medicinal activity is ensured fully, the medicament efficiency is increased, and the defect of poor absorptivity of the conventional roughly-processed product is overcome. The deer heart blood soft capsule has remarkable effects on coronary heart disease myocardial infarction, arrhythmia, myocardial ischemia, congestive heart failure, myocarditis, a rheumatic heart disease, cerebral thrombosis, angina, mental confusion, short breath, dizziness, palpitation, chest distress, chest pain, hypertension, hyperlipidemia and the like.

An interior-applied Chinese medicine for treating rheumatic heart disease is prepared from more than 12 Chinese-medicinal materials including astragalus root, tuckahoe, ginger, liquorice root, etc.

Disclosed is a Chinese medicament for treating rheumatic heart disease, wherein the recipe includes Chinese angelica root 15g, root of herbaceous peony 15g, poria cocos wolf 20g, dragon's bone 20g, spiny jujuba seed 20g, ginseng 6g, root of red rooted saliva 20g, safflower 6g, wolfberry fruit 15g, honey-fried licorice root 6g, wherein the ginseng can be substituted by pseudostellaria root 20g or radix adenophorae 20g. The medicament is prepared through conventional processes with easy accessibility of raw materials, simplified formulation and preparing procedures, and low cost of medicament production.

The invention discloses a traditional Chinese medicine composition for treating rheumatic heart diseases and a preparation method thereof. The composition consists of the following ingredients by weight percent: 18%-28% of nux vomica, 6%-12% of Sanguis Draxonis, 18%-28% of nutgrass galingale rhizome, 3%-5% of frankincense, 3%-5% of myrrh, 6%-10% of orange peel and 8%-12% of Szechuan Lovage Rhizome, wherein the sum of the weight percents of the raw materials is 100%. The preparation method of the composite is as follows: according to different properties of each traditional Chinese medicine, removing impurities, drying, smashing, grinding into fine powder and preparing medicinal powder. The composition of the invention has remarkable treatment effects on treating rheumatic heart diseases, in particular on aspects of cleaning impurities in blood vessels, dredging blood vessels, repairing the function insufficiency of valvula bicuspidalis, can simultaneously treat emphysema, has low side effects and safe pharmacy, can be taken for a long time, and has simple preparation method and convenient administration.

The preparation method of Chinese medicine oral liquor with the functions of relieving inflammation, stopping pain, promoting blood circulation, removing stasis, freezing channels, dispelling wind, eliminating dampness and dissipating cold for curing rheumatic arthritis, rheumatalgia, periarthritis of shoulder, cervical spondylopathy and rheumatic heart disease, which includes: placing the drynaris baronii, myrrh and frankincense in a gauze bag, placing the gauze bag in a ceramic container, adding the pure grain white liquor into the container, capping said container, then placing said container into a copper pot, sealing, heating, filtering the extract to obtain filtrate.